The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (17.22) USD. With the latest stock price at 14.14 USD, the upside of Neogenomics Inc based on DCF is -221.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 6.0% - 8.1% | 7.0% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (48.22) - (11.32) | (17.22) |
Upside | -441.0% - -180.0% | -221.8% |